Proactive Investors - Run By Investors For Investors

MMJ PhytoTech applies for ASX re-quotation, Canadian cannabis investment enters distribution agreement

TSX Venture Exchange-listed MediPharm Labs Inc will have its medicinal and recreational products distributed by a large-scale licensed producer.
MMJ PhytoTech applies for ASX re-quotation, Canadian cannabis investment enters distribution agreement
MMJ is a global cannabis investment company with a portfolio of minority holdings.

MMJ PhytoTech Ltd (ASX:MMJ) has confirmed its investment MediPharm Labs Inc (TSX-V:LABS) has entered into a cannabis concentrate program agreement with Emerald Health Therapeutics Inc (TSX-V:EMH).

MMJ’s investment in MediPharm amounts to CAD$5 million, comprising 5.88 million shares at 85 Canadian cents per share and 2.94 million warrants exercisable at CAD$1.20 a share by October 2020.

 

The company has also confirmed it has made the relevant re-quotation application to the ASX after its shareholders confirmed the disposal of MMJ subsidiary PhytoTech Therapeutics Ltd on October 5 and MMJ went into suspension.

Along with approving the disposal of PhytoTech Therapeutics to Harvest One Cannabis Inc (TSX-V:HVT), MMJ shareholders voted to change the company name to MMJ Group Holdings Limited.

READ: MMJ PhytoTech invests into major Canadian medical cannabis company

The MediPharm agreement enables Emerald to provide pharmaceutical-grade cannabis concentrate products produced by MediPharm to its large base of registered patients as well as premium concentrates for adult-use recreational consumers.

MediPharm is focused on downstream secondary extraction methodology, distillation and cannabinoid isolation and purification.

The company operates of one the largest cannabis concentrate manufacturing facilities in Canada and is built current good manufacturing practices and ISO standards.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full MMJ profile View Profile

MMJ Group Holdings Ltd Timeline

Related Articles

1541165310_canadian-flag-1.jpg
November 03 2018
Back Home Medical Cannabis Corp has agreed on a 24,000-kilogram three-year production and supply agreement
A visual representation of a drug candidate working in a dog
January 29 2019
The company has reaffirmed its upcoming milestones as it confirmed December quarter achievements.
RYAH vaporizer and cartridges
May 16 2019
RYAH is the first cannabis vaporizer that lets users precisely regulate dose and temperature

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use